Best Practice and Physician-Driven Networks
Lower prices often didn't result in increased market share. As a result, in the early 1990s we saw a kind of backlash against the bigger-is-better mentality, as suppliers regarded skeptically any group that had a membership too large to effectively manage, while rewarding (with better prices) those groups, particularly investor-owned hospital systems, that could mandate compliance.
You may also be interested in...
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.
In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.